Cargando…
Optimising future cervical screening strategies
The switch from primary cytology to primary high risk papillomavirus (HR-HPV) testing for cervical screening is now being implemented in a number of countries. The advantages of this are to increase screening sensitivity which will save lives, and at the same time to extend screening intervals. The...
Autor principal: | Kitchener, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522633/ https://www.ncbi.nlm.nih.gov/pubmed/30978414 http://dx.doi.org/10.1016/j.pvr.2019.04.001 |
Ejemplares similares
-
Cost-effectiveness of strategies to increase cervical screening
uptake at first invitation (STRATEGIC)
por: Tsiachristas, Apostolos, et al.
Publicado: (2017) -
Cervical screening during the COVID-19 pandemic: optimising recovery strategies
por: Castanon, Alejandra, et al.
Publicado: (2021) -
The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2022) -
Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening
por: Sargent, Alex, et al.
Publicado: (2019) -
Strategy for luminosity optimisation
por: White, S
Publicado: (2010)